Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2587611000168118 | Brevinor-1 28 Day (ethinyloestradiol 35 microgram + norethisterone 1 mg) uncoated tablet [21 tablets] (&) (inert substance) uncoated tablet [7 tablets], 4 x 28 tablets, blister packs | en | Synonym | Inactive | Case sensitive | Australian Medicines Terminology module |
| 4136931000168113 | Brevinor-1 28 Day (ethinylestradiol 35 microgram + norethisterone 1 mg) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 4 x 28 tablets, blister packs (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4145401000168118 | Brevinor-1 28 Day (ethinyloestradiol 35 microgram + norethisterone 1 mg) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 4 x 28 tablets, blister packs | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 447381000036110 | Brevinor-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 4 x 28, blister packs | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 447391000036112 | Brevinor-1 28 Day (ethinylestradiol 35 microgram + norethisterone 1 mg) uncoated tablet [21 tablets] (&) (inert substance) uncoated tablet [7 tablets], 4 x 28 tablets, blister packs (containered trade product pack) | en | Fully specified name | Inactive | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brevinor-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 4 x 28, blister packs | has TP | Brevinor-1 28 Day | true | Inferred relationship | Some | ||
| Brevinor-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 4 x 28, blister packs | has container type | blister pack | true | Inferred relationship | Some | ||
| Brevinor-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 4 x 28, blister packs | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Brevinor-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 4 x 28, blister packs | has TPUU | Brevinor-1 28 Day (inert substance) tablet | true | Inferred relationship | Some | 2 | |
| Brevinor-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 4 x 28, blister packs | has subpack | Brevinor-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 28, blister pack | true | Inferred relationship | Some | 1 | |
| Brevinor-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 4 x 28, blister packs | Is a | Brevinor-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 4 x 28 | true | Inferred relationship | Some | ||
| Brevinor-1 28 Day (21 x 1 mg/35 microgram tablets, 7 x inert tablets), 4 x 28, blister packs | has TPUU | Brevinor-1 28 Day (norethisterone 1 mg + ethinylestradiol 35 microgram) tablet | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR